Zepp Health (ZEPP) Research & Development (2016 - 2025)

Zepp Health's Research & Development history runs 10 years deep, the most recent figure standing at -$11.0 million for Q4 2025.

• In Q4 2025, Research & Development rose 0.71% year-over-year to -$11.0 million; the TTM figure through Dec 2025 stood at -$45.3 million (up 1.82% YoY), while the FY2025 annual figure was $45.3 million, down 1.82% from the prior year.
• Research & Development was -$11.0 million for Q4 2025 at Zepp Health, down from -$10.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $23.2 million in Q1 2021 to a low of -$24.8 million in Q2 2021.
• Historically, Research & Development has averaged -$12.6 million across 5 years, with a median of -$12.6 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Research & Development plunged 249.66% in 2021, then jumped 42.12% in 2023.
• A 5-year view of Research & Development shows it stood at -$14.7 million in 2021, then fell by 12.65% to -$16.6 million in 2022, then surged by 32.9% to -$11.1 million in 2023, then rose by 0.57% to -$11.1 million in 2024, then rose by 0.71% to -$11.0 million in 2025.
• The last three Research & Development figures came in at -$11.0 million (Q4 2025), -$10.8 million (Q3 2025), and -$11.2 million (Q2 2025), per Business Quant data.